• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    HepaRegeniX Raises €15M For HRX-215 Liver Regeneration Development

    GLOBENEWSWIRE

    HepaRegeniX publishes data for its first-in-class MKK4 inhibitor HRX-215

    GLOBENEWSWIRE

    HepaRegeniX Appoints Elias Papatheodorou as New Chairman of Board of Directors

    ACCESSWIRE

    HepaRegeniX initiates first-in-man Ph1 trial for lead MKK4 inhibitor HRX 0215

    PIPELINEREVIEW

    HepaRegeniX initiates first-in-man Ph1 trial for lead MKK4 inhibitor HRX 0215

    PIPELINEREVIEW

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.